Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1503, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept dominates therapy options for RA in Mexico
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
Access to resources
Recommend
Early etanercept worth it in RA therapy sequence
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. :
Tocilizumab dominates adalimumab for severe RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Etanercept: beneficial effects in early RA
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :